Literature DB >> 10816372

Expression and regulation of the streptokinase gene.

H Malke1, K Steiner, K Gase, C Frank.   

Abstract

Recent research in various areas has appreciably expanded our knowledge of streptokinase, a plasminogen activator produced by all human group A (GAS), group C (GCS), and group G (GGS) streptococci. Several molecular genetic approaches are described here to study the expression of the streptokinase gene, skn. Southern hybridization analysis demonstrated homology of synteny of ska, skc, and skg in the genomes of the above serogroups. S1 nuclease mapping, the use of transcriptional fusions to beta-galactosidase and luciferase reporter genes, in conjunction with site-directed mutagenesis, led to the localization of the core promoter region of skc and the identification of a cis-active upstream region required for full promoter activity. Circular permutation analysis of the promoter upstream region identified an intrinsic DNA bending locus as the pivotal DNA element stimulating the activity of the core promoter. The detection of skn allele-specific expression phenotypes, which proved not to be due to different skn mRNA half-lives, prompted allele swap experiments, showing that promoter activity is dictated by the host genetic background, rather than the sequence of the regulatory region. These findings suggest the involvement in skn expression of an as yet unidentified transcriptional activator that contacts the bent DNA region. Transcription termination of skc is directed by a bidirectional terminator whose structural requirements for termination efficiency were determined with base substitution mutants fused to a chloramphenicol acetyl transferase reporter. Finally, mutagenic plasmids are described for insertion-duplication and allele replacement mutagenesis of the skn locus. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816372     DOI: 10.1006/meth.2000.0982

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  7 in total

Review 1.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

2.  relA-Independent amino acid starvation response network of Streptococcus pyogenes.

Authors:  K Steiner; H Malke
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

3.  Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene.

Authors:  Christoph Fehr; Renee L Shirley; John K Belknap; John C Crabbe; Kari J Buck
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

4.  Pitfalls in screening streptococci for retrieving superior streptokinase (SK) genes: no activity correlation for streptococcal culture supernatant and recombinant SK.

Authors:  Malihe Keramati; Farzin Roohvand; Mohammad Mehdi Aslani; Fatemeh Motevalli; Shohreh Khatami; Arash Memarnejadian
Journal:  J Ind Microbiol Biotechnol       Date:  2012-10-25       Impact factor: 3.346

5.  Dual control of streptokinase and streptolysin S production by the covRS and fasCAX two-component regulators in Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Kerstin Steiner; Horst Malke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

6.  Mouse skin passage of a Streptococcus pyogenes Tn917 mutant of sagA/pel restores virulence, beta-hemolysis and sagA/pel expression without altering the position or sequence of the transposon.

Authors:  T H Eberhard; D D Sledjeski; M D Boyle
Journal:  BMC Microbiol       Date:  2001-12-17       Impact factor: 3.605

7.  Evidence for niche adaptation in the genome of the bovine pathogen Streptococcus uberis.

Authors:  Philip N Ward; Matthew T G Holden; James A Leigh; Nicola Lennard; Alexandra Bignell; Andy Barron; Louise Clark; Michael A Quail; John Woodward; Bart G Barrell; Sharon A Egan; Terence R Field; Duncan Maskell; Michael Kehoe; Christopher G Dowson; Neil Chanter; Adrian M Whatmore; Stephen D Bentley; Julian Parkhill
Journal:  BMC Genomics       Date:  2009-01-28       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.